Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.36EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
C.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.36ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
C.36ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
C.36EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
C.36EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
C.36ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.222EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.222EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.222ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.222ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.222EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.222EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.222ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.222ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.74EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.74EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.74ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.74ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.74EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.74EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.74ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.74ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.53EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.53EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.53ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.53ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.53EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.53EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.53ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.53ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JB.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JB.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JB.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JB.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JB.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JB.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JB.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
A.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
A.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used